YSB (HKSE:09885) EBIT : HK$28 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is YSB EBIT?

YSB's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$19 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$28 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. YSB's annualized ROC % for the quarter that ended in Jun. 2024 was -11.58%. YSB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 15.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. YSB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 1.12%.

YSB EBIT Historical Data

The historical data trend for YSB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB EBIT Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

-670.92

-605.60

-1,660.15

-3,500.27

27.45

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT	Get a 7-Day Free Trial			-946.50	-3,471.22	-29.06	19.37	8.24

Competitive Comparison of YSB's EBIT

For the Pharmaceutical Retailers subindustry, YSB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where YSB's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

YSB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$28 Mil.

YSB (HKSE:09885) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

YSB's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-69.124 * ( 1 - -5% )	/	( (524.105	+	729.159)	/ 2 )
=	-72.5802	/	626.632
=	-11.58 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5700.604	-	3396.991	-	( 2000.565	-	max(0, 3539.582	-	5319.09	+	2000.565	))
=	524.105

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5716.034	-	3344.829	-	( 2427.92	-	max(0, 3460.624	-	5102.67	+	2427.92	))
=	729.159

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

YSB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	38.734	/	( ( (229.383 + max(-389.351, 0))	+	(257.762 + max(-895.851, 0)) )	/	2 )
=	38.734	/	( ( 229.383	+	257.762 )	/	2 )
=	38.734	/	243.5725
=	15.90 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(34.741	+	1608.175	+	1375.998)	-	(3396.991	+	0	+	11.274)
=	-389.351

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(15.891	+	1358.445	+	1085.698)	-	(3344.829	+	0	+	11.056)
=	-895.851

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

YSB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	27.605	/	2465.347
	=	1.12 %

YSB EBIT Related Terms

Thank you for viewing the detailed overview of YSB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

B1S:Germany

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
H Capital V, L.p.	2101 Beneficial owner
Tmf (cayman) Ltd.	2301 Trustee
Tiger Global Private Investment Partners Xi, L.p.	2101 Beneficial owner
Tiger Global Pip Performance Xi, L.p.	2201 Interest of corporation controlled by you
Tiger Global Management, Llc	2102 Investment manager
Shleifer Scott	2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd.	2201 Interest of corporation controlled by you
Coleman Iii Charles	2201 Interest of corporation controlled by you
Miyt Worldwide Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner
Internet Fund V Pte. Ltd.	2306 Nominee for another person
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner

YSB Headlines

No Headlines